Explore the Global Memory-Enhancing Drugs Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036

Future Market Insights

Memory-Enhancing Drugs Market

Key Insight

Memory-enhancing drugs sales will rise through 2036, driven by cholinesterase inhibitors at a 40% share in 2026 as the leading drug class segment. The market was valued at USD 7.9 billion in 2025 and is expected to reach USD 14.24 billion by 2036, creating an incremental opportunity of USD 5.91 billion.

May 20, 2026

Anurag Sharma

275 Pages

Cite this Report

Memory-Enhancing Drugs Market

https://www.futuremarketinsights.com/reports/memory-enhancing-drugs-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

The Vanguard Group
Biogen Inc
Eisai Co. Ltd
Novartis
Pfizer Inc.
Takeda Pharmaceutical Company Limited
Berkshire Hathaway

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Memory-Enhancing Drugs Market

Key Players

Similar Industry Reports